Download PDF
Thromb Haemost 1997; 78(01): 678-683
DOI: 10.1055/s-0038-1657611
Angiogenesis
Schattauer GmbH Stuttgart

Angiogenesis in Embryos and Ischemic Diseases

Georg Breier
1   Department of Molecular Cell Biology, Max Planck Institute for Physiological and Clinical Research, Bad Nauheim
,
Annette Damert
1   Department of Molecular Cell Biology, Max Planck Institute for Physiological and Clinical Research, Bad Nauheim
,
Karl H Plate
2   Department of Neuropathology, Neurocenter, Freiburg University Medical School, Freiburg, Germany
,
Werner Risau
1   Department of Molecular Cell Biology, Max Planck Institute for Physiological and Clinical Research, Bad Nauheim
› Author Affiliations
Further Information

Publication History

Publication Date:
30 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Risau W, Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol 1995; 11: 73-91
    CrossrefPubMedGoogle Scholar
  • 2 Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med 1995; 1: 27-31
    CrossrefPubMedGoogle Scholar
  • 3 Breier G, Risau W. The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol 1996; 06: 454-456
    CrossrefPubMedGoogle Scholar
  • 4 Strömblad S, Cheresh DA. Cell adhesion and angiogenesis. Trends Cell Biol 1996; 6: 462-468
    CrossrefPubMedGoogle Scholar
  • 5 Ferrara N. Vascular endothelial growth factor. Trends Cardiovasc. Med 1993; 3: 244-250
    CrossrefPubMedGoogle Scholar
  • 6 Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-1312
    CrossrefPubMedGoogle Scholar
  • 7 Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med 1990; 172: 1535-1545
    CrossrefPubMedGoogle Scholar
  • 8 Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell Biol 1995; 129: 895-898
    CrossrefPubMedGoogle Scholar
  • 9 Davis-Smyth T, Chen H, Park J, Presta LG, Ferrara N. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may Initiate a signal transduction cascade. EMBO Journal 1996; 15: 4919-4927
    PubMedGoogle Scholar
  • 10 Kendall R, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Comm 1996; 226: 324-328
    CrossrefPubMedGoogle Scholar
  • 11 Clauss M, Weich H, Breier G, Knies U, Röckl W, Waltenberger J, Risau W. The vascular endothelial growth factor receptor Flt-1 mediates biological activities: implications for a functional role of placenta growth factor in monocyte activation and chemo-taxis. J.Biol. Chem 1996; 271: 17629-17634
    CrossrefPubMedGoogle Scholar
  • 12 Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc. Natl. Acad. Sci. USA 1991; 88: 9267-9271
    CrossrefPubMedGoogle Scholar
  • 13 Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-l/KDR. J. Biol. Chem 1994; 269: 25646-25654
    PubMedGoogle Scholar
  • 14 Cao YH, Chen H, Zhou L, Chiang MK, Anandapte B, Weatherbee J A, Wang YD, Fang FY, Flanagan JG, Tsang MLS. Heterodimers of placenta growth factor vascular endothelial growth factor – endothelial activity, tumor cell expression, and high affinity binding to Flk-l/KDR. J. Biol. Chem 1996; 271: 3154-3162
    CrossrefPubMedGoogle Scholar
  • 15 De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-991
    CrossrefPubMedGoogle Scholar
  • 16 Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Fltl, two receptors for vascular endothelial growth factor. J. Biol. Chem 1994; 269: 26988-26995
    PubMedGoogle Scholar
  • 17 Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 1995; 10: 135-147
    PubMedGoogle Scholar
  • 18 Guo D, Jia Q, Song HY, Warren RS, Donner DB. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem 1995; 270: 6729-6733
    CrossrefPubMedGoogle Scholar
  • 19 D’Angelo G, Struman I, Martial J, Weiner RI. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-termi-nal fragment of prolactin. Proc. Natl. Acad. Sci. U.SA 1995; 92: 6374-6378
    CrossrefPubMedGoogle Scholar
  • 20 Cunningham SA, Waxham MN, Arrate PM, Brock TA. Interaction of the Fit-1 tyrosine kinase receptor with the P85 subunit of phosphatidylinositol 3-kinase -mapping of a novel site involved in binding. J. Biol. Chem 1995; 270: 20254-20257
    CrossrefPubMedGoogle Scholar
  • 21 Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL. Characterization of vascular endothelial growth factor’s effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. Journal of Clinical Investigation 1996; 98: 2018-2026
    CrossrefPubMedGoogle Scholar
  • 22 Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-298
    PubMedGoogle Scholar
  • 23 Kaipainen A, Korhonen J, Mustonen T, Vanhinsbergh VWM, Fang GH, Dumont D, Breitman M, Alitalo K. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 1995; 92: 3566-3570
    CrossrefPubMedGoogle Scholar
  • 24 Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521-532
    PubMedGoogle Scholar
  • 25 Breier G, Clauss M, Risau W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev. Dyn 1995; 204: 228-239
    CrossrefPubMedGoogle Scholar
  • 26 Yamaguchi TP, Dumont D, Conlon RA, Breitman ML, Rossant J. flk-1, an fit-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 1993; 118: 489-498
    PubMedGoogle Scholar
  • 27 Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376: 62-66
    CrossrefPubMedGoogle Scholar
  • 28 Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376: 66-70
    CrossrefPubMedGoogle Scholar
  • 29 Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhard C, Desclerc C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-439
    CrossrefPubMedGoogle Scholar
  • 30 Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan K, Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-442
    CrossrefPubMedGoogle Scholar
  • 31 Flamme I, Von Reutern M, Drexler HCA, Syedali S, Risau W. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Dev. Biol 1995; 171: 399-414
    CrossrefPubMedGoogle Scholar
  • 32 Drake CJ, Little CD. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proc. Natl. Acad. Sci. USA 1995; 92: 7657-7661
    CrossrefPubMedGoogle Scholar
  • 33 Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Moller NP, Risau W, Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835-846
    CrossrefPubMedGoogle Scholar
  • 34 Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML. Vascularization of the mouse embryo -a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn 1995; 203: 80-92
    CrossrefPubMedGoogle Scholar
  • 35 Schnürch H, Risau W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 1993; 119: 957-968
    PubMedGoogle Scholar
  • 36 Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376: 70-74
    CrossrefPubMedGoogle Scholar
  • 37 Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC Yancopoulos GD. Isolation of Angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-1169
    CrossrefPubMedGoogle Scholar
  • 38 Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of Angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171-1180
    CrossrefPubMedGoogle Scholar
  • 39 Korhonen J, Polvi A, Partanen J, Alitalo K. The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis. Oncogene 1994; 09: 395-403
    PubMedGoogle Scholar
  • 40 Sato TN, Qin Y, Kozak CA, Audus KL. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. USA 1993; 90: 9355-9358
    CrossrefPubMedGoogle Scholar
  • 41 Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-848
    CrossrefPubMedGoogle Scholar
  • 42 Plate KH, Breier G, Risau W. Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994; 04: 207-218
    CrossrefPubMedGoogle Scholar
  • 43 Ferrara N. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res. Treatm 1995; 36: 127-137
    CrossrefPubMedGoogle Scholar
  • 44 Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362: 841-844
    CrossrefPubMedGoogle Scholar
  • 45 Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 1994; 367: 576-579
    CrossrefPubMedGoogle Scholar
  • 46 Saleh M, Stacker S A, Wilks AF. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 1996; 56: 393-401
    PubMedGoogle Scholar
  • 47 Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487
    CrossrefPubMedGoogle Scholar
  • 48 Miller JW, Adamis AP, Shima DT, D’Amore PA, Moulton RS, O’Reilly MS, Folkman J, Dvorak HF, Brown LF. et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol 1994; 145: 574-584
    PubMedGoogle Scholar
  • 49 Pe’er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Brit. J. Ophthalmol 1996; 80: 241-245
    CrossrefPubMedGoogle Scholar
  • 50 Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D’Amore PA, Miller JW. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch. Ophthalmol 1996; 114: 66-71
    CrossrefPubMedGoogle Scholar
  • 51 Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab. Invest 1996; 74: 819-825
    PubMedGoogle Scholar
  • 52 Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845
    CrossrefPubMedGoogle Scholar
  • 53 Forsythe JA, Jiang B, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol 1996; 16: 4604-4613
    CrossrefPubMedGoogle Scholar
  • 54 Ikeda I, Achen MG, Breier G, Risau W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem 1995; 270: 19761-19766
    CrossrefPubMedGoogle Scholar
  • 55 Alon T, Hemo I, Itin A, Peer J, Stone J, Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med 1995; 01: 1024-1028
    CrossrefPubMedGoogle Scholar
  • 56 Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, Flk-1 and Flt-1 expression in a rat myocardialinfarction model of angiogenesis. Am. J. Physiol 1996; 39: 1803-1811
    PubMedGoogle Scholar
  • 57 Tuder RM, Flook BE, Voelkel NF. Increased gene expression for VEGF and the VEGF receptors KDR/flk and fit in lungs exposed to acute or to chronic hypoxia -modulation of gene expression by nitric oxide. J. Clin. Invest 1995; 95: 1798-1807
    CrossrefPubMedGoogle Scholar
  • 58 Kovacs Z, Ikezaki K, Samoto K, Inamura T, Fukui M. VEGF and Fit -expression time kinetics in rat brain infarct. Stroke 1996; 27: 1865-1872
    CrossrefPubMedGoogle Scholar
  • 59 Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90: 649-652
    CrossrefPubMedGoogle Scholar
  • 60 Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J. Exp. Med 1994; 180: 1141-1146
    CrossrefPubMedGoogle Scholar
  • 61 Frank S, Hübner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes: implications for normal and impaired wound healing. J. Biol. Chem 1995; 270: 12607-12613
    CrossrefPubMedGoogle Scholar
  • 62 Wizigmann-Voos S, Breier G, Risau W, Plate KH. Up-regula-tion of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and in sporadic hemangioblastomas. Cancer Res 1995; 55: 1358-1364
    PubMedGoogle Scholar
  • 63 Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD, Linehan WM. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA 1996; 93: 10589-10594
    CrossrefPubMedGoogle Scholar
  • 64 Kieser A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994; 9: 963-969
    PubMedGoogle Scholar
  • 65 Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia 1995; 15: 339-347
    CrossrefPubMedGoogle Scholar
  • 66 Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel RS. Mutant ras oncogenes upregulate VEGF/VPF expression -implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995; 55: 4575-4580
    PubMedGoogle Scholar
  • 67 Mazure NM, Chen EY, Yeh P, Laderoute KR, Giaccia AJ. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res 1996; 56: 3436-3440
    PubMedGoogle Scholar
  • 68 Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest 1996; 97: 469-476
    CrossrefPubMedGoogle Scholar
  • 69 Rönicke V, Risau W, Breier G. Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2(Flk-1) promoter. Circulation Res 1996; 79: 277-285
    CrossrefPubMedGoogle Scholar
  • 70 Olofsson B, Paiusola K, Kaipainen A, Von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc. Natl. Acad. Sci. USA 1996; 93: 2575-2581
    PubMedGoogle Scholar